Sign up to save your podcasts
Or
Share The Altissimo Study using a TKI for nAMD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Altissimo Study using a TKI for nAMD
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
View all episodes
By Retina Synthesis
4.5
88 ratings
We review the results of the phase I Graybug study Altissimo using sustained release tyrosinase kinase inhibitor for long term treatment of neovascular AMD with Dr. Veeral Sheth, Chicago, Illinois, Assistant Clinical Professor University of Illinois at Chicago.
More shows like Retina Synthesis
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
18 Listeners
Straight From The Cutter's Mouth: A Retina Podcast
99 Listeners
The Daily
113,159 Listeners
Up First from NPR
56,945 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Indicator from Planet Money
9,560 Listeners
The Retina Channel Podcast
12 Listeners
Dateline NBC
47,707 Listeners
Experts InSight
51 Listeners
RETINA Journal Podcasts
11 Listeners
Knock Knock, Hi! with the Glaucomfleckens
467 Listeners
Ophthalmology Journal
19 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners